# A Study of DA-302168S in Participants With Overweight/Obesity

> **NCT07629544** · PHASE3 · RECRUITING · sponsor: **Chendu DIAO Pharmaceutical Group CO., LTD.** · enrollment: 840 (estimated)

## Conditions studied

- Overweight and Obesity

## Interventions

- **DRUG:** DA-302168S
- **DRUG:** DA-302168S
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07629544
- **Lead sponsor:** Chendu DIAO Pharmaceutical Group CO., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-19
- **Primary completion:** 2027-07-09
- **Final completion:** 2027-10-19
- **Target enrollment:** 840 (ESTIMATED)
- **Last updated:** 2026-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07629544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07629544, "A Study of DA-302168S in Participants With Overweight/Obesity". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07629544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*